|
End-of-day quote
Shenzhen S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 9.050 CNY | -2.79% |
|
-8.68% | -14.46% |
| Market Cap | 4.36B 648M 558M 523M 478M 900M 61.92B 903M 6.21B 2.42B 31.26B 2.43B 2.38B 104B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.82B 419M 361M 338M 309M 582M 40.01B 584M 4.01B 1.57B 20.2B 1.57B 1.54B 66.98B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.82% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | -2.79% | ||
| 1 week | -8.68% | ||
| Current month | +2.84% | ||
| 1 month | +2.14% | ||
| 3 months | +3.67% | ||
| 6 months | -20.33% | ||
| Current year | -14.46% |
| 1 week | 8.9 |  | 9.9 |
| 1 month | 8.48 | | 10.86 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 14.18 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.79% | -8.68% | -31.90% | -17.05% | 648M | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,047B | |
| +0.85% | -0.81% | +52.77% | +63.15% | 646B | |
| -1.03% | -3.58% | +22.87% | +73.29% | 451B | |
| -1.46% | -4.50% | +37.43% | +38.41% | 355B | |
| -0.72% | -2.89% | +21.86% | +36.79% | 291B | |
| -1.19% | -2.21% | +1.35% | +12.29% | 252B | |
| -1.05% | -1.57% | +51.40% | +68.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.29% | 203B | |
| -2.14% | -0.30% | +29.42% | +89.10% | 181B | |
| Average | -0.97% | -2.41% | +22.81% | +42.23% | 365.99B | |
| Weighted average by Cap. | -0.48% | -3.46% | +38.65% | +65.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 61.9M 53.34M 50.01M 45.65M 86.01M 5.92B 86.28M 593M 232M 2.99B 232M 227M 9.9B | 405M 60.15M 51.83M 48.6M 44.36M 83.58M 5.75B 83.84M 577M 225M 2.9B 226M 221M 9.62B |
| Net income | -68.85M -10.23M -8.82M -8.27M -7.55M -14.22M -978M -14.26M -98.09M -38.27M -494M -38.42M -37.59M -1.64B | 14.57M 2.17M 1.87M 1.75M 1.6M 3.01M 207M 3.02M 20.76M 8.1M 104M 8.13M 7.95M 346M |
| Net Debt | -1.57B -234M -201M -189M -172M -325M -22.33B -326M -2.24B -874M -11.27B -877M -858M -37.37B | -1.54B -229M -198M -185M -169M -318M -21.91B -319M -2.2B -857M -11.06B -861M -842M -36.67B |
Employees
489
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | CN¥9.050 | -2.79% | 7,146,900 |
| 26-08-27 | CN¥9.310 | +0.22% | 8,720,700 |
| 26-08-26 | CN¥9.290 | -0.21% | 10,837,776 |
| 26-08-25 | CN¥9.310 | +2.87% | 11,184,500 |
| 26-08-24 | CN¥9.050 | -8.68% | 16,430,638 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
